Pearl River Capital’s Idexx Laboratories IDXX Stock Holding History

Pearl River Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,014	Closed	-$981K	–	175
2024 Q2	$981K	Buy	+2,014	New	+$1.01M	0.16%	187
2024 Q1	–	Sell	-1,580	Closed	-$877K	–	569
2023 Q4	$877K	Sell	1,580 -884	-36%	-$415K	0.14%	221
2023 Q3	$1.08M	Buy	2,464 +858	+53%	+$428K	0.17%	205
2023 Q2	$807K	Buy	1,606 +981	+157%	+$470K	0.13%	237
2023 Q1	$313K	Buy	+625	New	+$299K	0.05%	402
2022 Q2	–	Sell	-954	Closed	-$522K	–	495
2022 Q1	$522K	Buy	+954	New	+$502K	0.14%	220
2021 Q2	–	Sell	-955	Closed	-$467K	–	488
2021 Q1	$467K	Buy	+955	New	+$478K	0.15%	207
2020 Q1	–	Sell	-2,414	Closed	-$630K	–	606
2019 Q4	$630K	Buy	2,414 +2,310	+2,221%	+$609K	0.23%	121
2019 Q3	$28K	Buy	+104	New	+$28.9K	0.08%	242
2019 Q1	–	Sell	-152	Closed	-$28K	–	547
2018 Q4	$28K	Buy	+152	New	+$31.2K	0.13%	202

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pearl River Capital's IDXX Position: Q3 2024 in Review

Pearl River Capital sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 2,014 shares — an estimated $981K sold.

Pearl River Capital first reported a position in IDXX in Q4 2018 and held it in 10 quarters. The position peaked at $1.08M in Q3 2023. 1,115 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

Pearl River Capital reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
Pearl River Capital sold 2,014 Idexx Laboratories shares in Q3 2024, an estimated $981K.
Pearl River Capital first reported a position in Idexx Laboratories in Q4 2018 and held it in 10 quarters.
Pearl River Capital's Idexx Laboratories position peaked at $1.08M in Q3 2023.
1,115 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Pearl River Capital's 13F filing for Q3 2024.